Ritchie Edward Brown, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wakefulness | 13 | 2024 | 1264 | 1.870 |
Why?
|
| Parvalbumins | 11 | 2023 | 260 | 1.500 |
Why?
|
| Neurons | 23 | 2023 | 9428 | 1.150 |
Why?
|
| Arousal | 5 | 2022 | 1171 | 1.030 |
Why?
|
| Histamine | 12 | 2003 | 499 | 1.000 |
Why?
|
| Sleep | 14 | 2024 | 4759 | 0.970 |
Why?
|
| Prosencephalon | 3 | 2016 | 305 | 0.870 |
Why?
|
| Neuropeptides | 10 | 2010 | 944 | 0.850 |
Why?
|
| Sleep, REM | 7 | 2020 | 595 | 0.840 |
Why?
|
| gamma-Aminobutyric Acid | 11 | 2022 | 1139 | 0.820 |
Why?
|
| Glutamate Decarboxylase | 4 | 2014 | 239 | 0.800 |
Why?
|
| Synaptic Transmission | 10 | 2013 | 1167 | 0.770 |
Why?
|
| Cholinergic Agents | 2 | 2021 | 96 | 0.730 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2010 | 2871 | 0.700 |
Why?
|
| Patch-Clamp Techniques | 11 | 2018 | 924 | 0.680 |
Why?
|
| Dentate Gyrus | 5 | 1999 | 165 | 0.640 |
Why?
|
| Action Potentials | 8 | 2017 | 1830 | 0.630 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1132 | 0.600 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2018 | 150 | 0.560 |
Why?
|
| Schizophrenia | 6 | 2020 | 6930 | 0.530 |
Why?
|
| Carbachol | 3 | 2017 | 223 | 0.510 |
Why?
|
| Glutamates | 1 | 2017 | 385 | 0.510 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2018 | 446 | 0.480 |
Why?
|
| Neurotransmitter Agents | 5 | 2009 | 664 | 0.460 |
Why?
|
| Ventral Tegmental Area | 4 | 2004 | 132 | 0.440 |
Why?
|
| Rats, Wistar | 17 | 2003 | 1848 | 0.430 |
Why?
|
| Parasympathetic Nervous System | 1 | 2014 | 143 | 0.430 |
Why?
|
| Long-Term Potentiation | 8 | 2006 | 290 | 0.420 |
Why?
|
| Sleep Deprivation | 4 | 2023 | 847 | 0.420 |
Why?
|
| Receptors, Histamine H3 | 5 | 2001 | 11 | 0.420 |
Why?
|
| Electroencephalography | 13 | 2022 | 6242 | 0.400 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 2062 | 0.400 |
Why?
|
| Substantia Nigra | 3 | 2004 | 347 | 0.400 |
Why?
|
| Raphe Nuclei | 3 | 2003 | 104 | 0.400 |
Why?
|
| Carrier Proteins | 7 | 2004 | 4935 | 0.380 |
Why?
|
| Adenosine | 3 | 2018 | 805 | 0.380 |
Why?
|
| Receptors, Neuropeptide | 7 | 2013 | 106 | 0.350 |
Why?
|
| Animals | 56 | 2024 | 168079 | 0.350 |
Why?
|
| Glutamic Acid | 4 | 2021 | 1173 | 0.340 |
Why?
|
| Cerebral Cortex | 3 | 2014 | 5775 | 0.340 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2021 | 53 | 0.330 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 1995 | 195 | 0.330 |
Why?
|
| Ketamine | 2 | 2013 | 517 | 0.320 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2009 | 109 | 0.320 |
Why?
|
| Serotonin | 3 | 2003 | 1042 | 0.320 |
Why?
|
| Veterans | 1 | 2022 | 2654 | 0.300 |
Why?
|
| Reticular Formation | 1 | 2008 | 59 | 0.300 |
Why?
|
| Membrane Potentials | 7 | 2014 | 1088 | 0.290 |
Why?
|
| Brain Waves | 3 | 2019 | 409 | 0.290 |
Why?
|
| Pyramidal Cells | 1 | 2009 | 366 | 0.280 |
Why?
|
| Hypothalamic Area, Lateral | 4 | 2003 | 108 | 0.280 |
Why?
|
| Mice | 25 | 2023 | 81326 | 0.280 |
Why?
|
| Hippocampus | 8 | 2022 | 3754 | 0.280 |
Why?
|
| Cholinergic Agonists | 1 | 2006 | 75 | 0.270 |
Why?
|
| Rats | 24 | 2013 | 23704 | 0.270 |
Why?
|
| Mice, Transgenic | 4 | 2024 | 9520 | 0.260 |
Why?
|
| Gene Knock-In Techniques | 3 | 2013 | 420 | 0.260 |
Why?
|
| Dopamine | 5 | 2004 | 1601 | 0.250 |
Why?
|
| Pons | 1 | 2006 | 240 | 0.250 |
Why?
|
| Tetrodotoxin | 4 | 2017 | 245 | 0.250 |
Why?
|
| Cell Membrane | 1 | 2013 | 3661 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 7 | 2013 | 1249 | 0.220 |
Why?
|
| Neural Inhibition | 2 | 2006 | 586 | 0.200 |
Why?
|
| Receptors, Glutamate | 2 | 2018 | 227 | 0.190 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 2219 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8603 | 0.180 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1558 | 0.180 |
Why?
|
| Homeostasis | 2 | 2010 | 3320 | 0.180 |
Why?
|
| Carbazoles | 1 | 2002 | 220 | 0.180 |
Why?
|
| Calcium Channels, T-Type | 1 | 2020 | 28 | 0.170 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 1997 | 142 | 0.170 |
Why?
|
| Avoidance Learning | 1 | 2021 | 247 | 0.170 |
Why?
|
| Neostriatum | 1 | 2001 | 247 | 0.160 |
Why?
|
| Thalamus | 2 | 2022 | 1046 | 0.160 |
Why?
|
| Electric Stimulation | 4 | 2017 | 1736 | 0.160 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2018 | 13 | 0.160 |
Why?
|
| Histamine Antagonists | 4 | 2002 | 93 | 0.160 |
Why?
|
| Acoustic Stimulation | 2 | 2020 | 1240 | 0.160 |
Why?
|
| Thalamic Nuclei | 1 | 2019 | 111 | 0.160 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2018 | 67 | 0.150 |
Why?
|
| Calcium Channel Blockers | 3 | 2017 | 691 | 0.150 |
Why?
|
| Attention | 2 | 2023 | 2394 | 0.150 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 531 | 0.150 |
Why?
|
| Narcolepsy | 3 | 2009 | 199 | 0.150 |
Why?
|
| Carbohydrates | 1 | 2020 | 389 | 0.150 |
Why?
|
| Theta Rhythm | 2 | 2004 | 219 | 0.150 |
Why?
|
| Electrodes, Implanted | 2 | 2018 | 839 | 0.140 |
Why?
|
| Neuronal Plasticity | 4 | 2015 | 1432 | 0.140 |
Why?
|
| Animals, Newborn | 2 | 2017 | 2665 | 0.140 |
Why?
|
| Luminescent Proteins | 2 | 2017 | 834 | 0.140 |
Why?
|
| Histamine Agonists | 1 | 1996 | 13 | 0.140 |
Why?
|
| Neural Pathways | 3 | 2012 | 3056 | 0.140 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2002 | 369 | 0.130 |
Why?
|
| Azetidinecarboxylic Acid | 1 | 1995 | 4 | 0.130 |
Why?
|
| Electrophysiology | 5 | 2002 | 1262 | 0.130 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 172 | 0.130 |
Why?
|
| Cycloleucine | 1 | 1995 | 7 | 0.130 |
Why?
|
| Ion Channels | 3 | 2014 | 1038 | 0.120 |
Why?
|
| Male | 33 | 2024 | 360693 | 0.120 |
Why?
|
| Neurotoxins | 1 | 1995 | 240 | 0.120 |
Why?
|
| Glycine | 2 | 1995 | 659 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2019 | 584 | 0.110 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 11067 | 0.110 |
Why?
|
| Muscarinic Agonists | 1 | 2014 | 91 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2013 | 8164 | 0.110 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2014 | 156 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 2014 | 157 | 0.110 |
Why?
|
| Receptors, GABA-A | 2 | 2022 | 621 | 0.110 |
Why?
|
| Tegmentum Mesencephali | 1 | 2013 | 59 | 0.100 |
Why?
|
| Brain | 4 | 2017 | 27092 | 0.100 |
Why?
|
| Benzoates | 1 | 1994 | 211 | 0.100 |
Why?
|
| Lysine | 1 | 2017 | 982 | 0.100 |
Why?
|
| Interneurons | 2 | 2011 | 587 | 0.100 |
Why?
|
| Piperidines | 2 | 2017 | 1656 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 1988 | 0.100 |
Why?
|
| Receptors, Histamine | 2 | 2002 | 23 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2115 | 0.100 |
Why?
|
| Synapses | 2 | 2005 | 1755 | 0.100 |
Why?
|
| Benzamides | 1 | 2017 | 1371 | 0.090 |
Why?
|
| Evoked Potentials | 2 | 2013 | 1047 | 0.090 |
Why?
|
| Darkness | 1 | 2010 | 158 | 0.090 |
Why?
|
| Locus Coeruleus | 2 | 2010 | 230 | 0.090 |
Why?
|
| Pyrimidines | 2 | 2017 | 3027 | 0.090 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2009 | 42 | 0.090 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 89 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1490 | 0.080 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 793 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 908 | 0.070 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 1997 | 70 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 4404 | 0.070 |
Why?
|
| Cognition | 2 | 2015 | 6988 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 894 | 0.070 |
Why?
|
| Analgesics | 1 | 2013 | 1068 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 88 | 0.070 |
Why?
|
| Basal Nucleus of Meynert | 1 | 2005 | 24 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1602 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 370 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2013 | 1769 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 880 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1751 | 0.060 |
Why?
|
| Electromyography | 3 | 2017 | 1393 | 0.060 |
Why?
|
| Maze Learning | 1 | 2006 | 481 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 540 | 0.050 |
Why?
|
| Norepinephrine | 2 | 2004 | 897 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18220 | 0.050 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 2002 | 18 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2009 | 4111 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2002 | 42 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2190 | 0.050 |
Why?
|
| Sleep Stages | 2 | 2017 | 695 | 0.050 |
Why?
|
| Calcium Channels | 2 | 2003 | 620 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2002 | 102 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2002 | 119 | 0.050 |
Why?
|
| Hypothalamic Hormones | 1 | 2003 | 145 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2002 | 177 | 0.050 |
Why?
|
| Pituitary Hormones | 1 | 2003 | 182 | 0.050 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2001 | 29 | 0.050 |
Why?
|
| Humans | 15 | 2022 | 761208 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 4567 | 0.050 |
Why?
|
| Proteomics | 2 | 2012 | 3840 | 0.050 |
Why?
|
| Melanins | 1 | 2003 | 289 | 0.040 |
Why?
|
| Appetite Regulation | 1 | 2001 | 84 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 13367 | 0.040 |
Why?
|
| Emotions | 1 | 2012 | 2742 | 0.040 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2001 | 151 | 0.040 |
Why?
|
| Animal Feed | 1 | 2020 | 110 | 0.040 |
Why?
|
| Receptors, GABA | 1 | 2002 | 312 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 998 | 0.040 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 1999 | 45 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2012 | 23416 | 0.040 |
Why?
|
| Acetylcholine | 2 | 2016 | 629 | 0.040 |
Why?
|
| 4-Aminopyridine | 1 | 1999 | 80 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 1999 | 161 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 1998 | 225 | 0.040 |
Why?
|
| Histamine H1 Antagonists | 1 | 1998 | 101 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 2001 | 1462 | 0.040 |
Why?
|
| Sodium | 1 | 2002 | 1589 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 306 | 0.030 |
Why?
|
| Tetanus | 1 | 1997 | 51 | 0.030 |
Why?
|
| Receptors, Presynaptic | 1 | 1996 | 15 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 1998 | 166 | 0.030 |
Why?
|
| Reaction Time | 1 | 2023 | 2087 | 0.030 |
Why?
|
| Genomics | 1 | 2012 | 5828 | 0.030 |
Why?
|
| Picrotoxin | 1 | 1995 | 61 | 0.030 |
Why?
|
| Resorcinols | 1 | 1995 | 41 | 0.030 |
Why?
|
| Biological Assay | 1 | 2019 | 623 | 0.030 |
Why?
|
| Microdialysis | 1 | 2016 | 161 | 0.030 |
Why?
|
| Pyrroles | 1 | 2002 | 1124 | 0.030 |
Why?
|
| Pyrilamine | 1 | 1995 | 13 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1997 | 335 | 0.030 |
Why?
|
| Cimetidine | 1 | 1995 | 76 | 0.030 |
Why?
|
| Kinetics | 1 | 2003 | 6312 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2016 | 167 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 22127 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 428 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 230 | 0.030 |
Why?
|
| Phenotype | 1 | 2012 | 16575 | 0.030 |
Why?
|
| Indoles | 1 | 2002 | 1830 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.030 |
Why?
|
| Axons | 1 | 2001 | 1671 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3412 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3702 | 0.020 |
Why?
|
| Photoperiod | 1 | 2013 | 139 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 900 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2569 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 1178 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17897 | 0.020 |
Why?
|
| Microinjections | 1 | 2010 | 321 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2009 | 69 | 0.020 |
Why?
|
| Data Collection | 1 | 2019 | 3320 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 1984 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2009 | 141 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 517 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10756 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2001 | 705 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2003 | 18926 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2691 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1495 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2005 | 51 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 152 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 283 | 0.020 |
Why?
|
| Corticosterone | 1 | 2006 | 301 | 0.020 |
Why?
|
| Female | 4 | 2019 | 392544 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 3832 | 0.010 |
Why?
|
| Mice, Knockout | 3 | 2009 | 14392 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2013 | 12747 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2004 | 174 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1873 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1999 | 5662 | 0.010 |
Why?
|
| Histidine Decarboxylase | 1 | 2001 | 12 | 0.010 |
Why?
|
| Autoreceptors | 1 | 2001 | 5 | 0.010 |
Why?
|
| Tubulin | 1 | 2005 | 692 | 0.010 |
Why?
|
| Diet | 1 | 2020 | 8048 | 0.010 |
Why?
|
| Nitroarginine | 1 | 2001 | 66 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2001 | 73 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 302 | 0.010 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2001 | 90 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3836 | 0.010 |
Why?
|
| Nickel | 1 | 2001 | 126 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 940 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7571 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14025 | 0.010 |
Why?
|
| Receptors, Histamine H2 | 1 | 1997 | 18 | 0.010 |
Why?
|
| Receptors, Histamine H1 | 1 | 1997 | 19 | 0.010 |
Why?
|
| Biogenic Amines | 1 | 1997 | 53 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1999 | 395 | 0.010 |
Why?
|
| Potassium | 1 | 2001 | 1309 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1997 | 201 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20119 | 0.010 |
Why?
|
| Cell Separation | 1 | 2001 | 1721 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1997 | 563 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 481 | 0.010 |
Why?
|
| Time Factors | 1 | 1995 | 39957 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 7571 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2004 | 2867 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 14675 | 0.000 |
Why?
|